molybdenum has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annušová, A; Čepcová, L; Elefantová, K; Hofbauerová, M; Jergel, M; Kálosi, A; Lakatoš, B; Majková, E; Šiffalovič, P; Štefík, P | 1 |
1 other study(ies) available for molybdenum and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS
Topics: Antineoplastic Agents; Cell Line, Tumor; Disulfides; Drug Delivery Systems; Humans; Leukemia, Myeloid, Acute; Molybdenum; Nanoconjugates; Nonlinear Optical Microscopy; Sialic Acid Binding Ig-like Lectin 3 | 2021 |